MAM
ARIA

Meeder Asset Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Meeder Asset Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,200
Closed -$39K – 983
2015
Q4 		$39K Buy
+6,200
New +$40.7K ﹤0.01% 702

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Meeder Asset Management's ARIA Position: Q1 2016 in Review

Meeder Asset Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2016, closing a stake of 6,200 shares — an estimated $39K sold.

Meeder Asset Management first reported a position in ARIA in Q4 2015 and held it in 1 quarter. The position peaked at $39K in Q4 2015. 162 funds tracked by Wall St. Rank hold ARIA as of Q1 2016.

  • Meeder Asset Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
  • Meeder Asset Management sold 6,200 Ariad Pharmaceuticals Inc shares in Q1 2016, an estimated $39K.
  • Meeder Asset Management first reported a position in Ariad Pharmaceuticals Inc in Q4 2015 and held it in 1 quarter.
  • Meeder Asset Management's Ariad Pharmaceuticals Inc position peaked at $39K in Q4 2015.
  • 162 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2016.

Based on Meeder Asset Management's 13F filing for Q1 2016, filed 12 May 2016.